Plain-English translation of NCT07245732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a single injection of methylprednisolone works as well as taking oral prednisone pills to control sudden flare-ups of rheumatoid arthritis. Researchers want to understand which approach is better at reducing pain and swelling, and which one feels better from a patient's perspective. Both are steroids—medications that calm inflammation—but they're given in different ways.
Doctors often use steroids to treat RA flare-ups, but no one has directly compared whether the injection or the pills work better. Patients' experiences and preferences matter just as much as medical measurements, so this study is trying to figure out which approach helps people feel better faster and with fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial during an RA flare-up, you'll be randomly assigned to either take prednisone pills by mouth for about 3 weeks (starting at 15 mg daily and gradually decreasing) or receive a single 120 mg injection of methylprednisolone into your arm muscle. You'll track your pain, swelling, fatigue, and how you're feeling over the following weeks, and the research team will check in to see how well the treatment is working for you.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Canada